By
Bryan Cohen
Published: Dec. 12, 2012, 2:43 p.m.·
Tags:
None
The TB Trials Consortium recently announced that it had enrolled its first participant in TBTC Study 33, an evaluation of the self-administration of a 12-dose latent tuberculosis infection regimen.
Read More →